Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1980-01-24
1982-07-27
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 260112R, 260112B, A61K 4300, G01N 3356, G01N 3360
Patent
active
043417540
ABSTRACT:
A cerebral spinal fluid diagnostic reagent for herpes simplex virus encephalitis consists essentially of the glycoprotein derived from Type 1 herpes simplex virus (HSV-1) having an approximate molecular weight of 132,000 which is antigenically reactive with HSV-1 antiserum. The reactive protein is in radiolabeled form and comprises at least 50% of the total radiolabeled protein present in the reagent.
REFERENCES:
patent: 4205057 (1980-05-01), Whitaker
Chen et al., Virology, 91, 1978, pp. 234-242.
Lombardi et al., Chem. Abstracts, vol. 86, 1977, Abstract #696967.
Chen Anthony B.
Kaplan Albert S.
Kaplan Tamar B.
Nucker Christine M.
Vanderbilt University
LandOfFree
Diagnostic reagent for herpes simplex virus encephalitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic reagent for herpes simplex virus encephalitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic reagent for herpes simplex virus encephalitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2024882